Trinity Biotech TRIB
NASDAQ TRIB
$6.79 +0.04 (+0.56%)
As of: Sep 30, 2026 · 1:03 PM EDT

Trinity Biotech Plc (TRIB) EBITDA Margin (2021 - 2024)

Updated

Trinity Biotech (TRIB) recorded EBITDA Margin of -32.90% in the year ended Dec 31, 2025, down 0.45 percentage points from -32.45% a year earlier.

Analysis

Trinity Biotech Plc (TRIB) EBITDA Margin (2021 - 2024) Analysis & Trends

Starting with the year ended Dec 31, 2009, Trinity Biotech's EBITDA Margin history includes 17 years.

  • Annual EBITDA Margin has a five-year change of -34.35 percentage points (years ended Dec 2020 to Dec 2025).
  • Annual EBITDA Margin has ranged from -45.92% in the year ended Dec 31, 2023 to 5.98% in the year ended Dec 31, 2021 over the past five years.
  • Per Business Quant data, TRIB's EBITDA Margin was -32.45% in the year ended Dec 31, 2024 (+13.47 pp), -45.92% in the year ended Dec 31, 2023 (-16.45 pp), -29.47% in the year ended Dec 31, 2022 (-35.45 pp) and 5.98% in the year ended Dec 31, 2021 (+4.53 pp).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -71.92%
Sep 30, 2024 -12.94%
Jun 30, 2024 -22.82%
Mar 31, 2024 -17.10%
Dec 31, 2023 -24.72%
Sep 30, 2023 -29.90%
Jun 30, 2023 -104.29%
Mar 31, 2023 -24.74%
Dec 31, 2022 -50.51%
Sep 30, 2022 -50.08%
Jun 30, 2022 -10.61%
Mar 31, 2022 -6.30%
Dec 31, 2021 4.05%
Sep 30, 2021 13.63%
Jun 30, 2021 1.77%
API Access

Trinity Biotech Plc EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TRIB&period=max&api_key=YOUR_API_KEY